PeptidePedia The community reference

Liquid chromatography-mass spectrometry (revision 4)

Old revision·19:05, 14 Oct 2024·AnalyticalAnnie

This is an old revision of this page, as it stood at 19:05, 14 Oct 2024, saved by AnalyticalAnnie with the summary split §Principle from §Practical limitations. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Liquid chromatography-mass spectrometry
AbbreviationLC-MS
CombinesChromatographic separation and mass detection
InterfaceUsually electrospray
AddsIdentity to a retention-based separation
Analytical method infobox · conventions

Liquid chromatography-mass spectrometry couples a chromatographic separation to a mass spectrometer, so that each eluting peak is characterised by both its retention time and its mass. It converts a weak identification into a strong one.[1]

The interface is almost always electrospray, which works directly from flowing solution. This compatibility is what made the technique routine, and it constrains the chromatography: mobile phases must be volatile and free of non-volatile buffers.[2]

What it adds over either alone

[edit]

Chromatography alone establishes that one species dominates; mass spectrometry alone establishes that a species of the expected mass is present. Together they establish that the dominant species has the expected mass, which is a materially stronger statement than either.[1]

Impurity identification is where the combination is most valuable. A deletion sequence appears as a peak of lower mass by one residue; an oxidised species by 16 Da more; an incompletely deprotected species by the mass of the retained group. See Resin cleavage and Solid-phase peptide synthesis.[3]

References

  1. ^ a b Aebersold R, Mann M. "Mass spectrometry-based proteomics." Nature 422(6928):198–207 (2003). PMID 12634793.
  2. ^ Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. "Electrospray ionization for mass spectrometry of large biomolecules." Science 246(4926):64–71 (1989). PMID 2675315.
  3. ^ United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.